Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 19/20 | 0.37 |
| ▸ | CNR1 | P21554 | 18/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26252956 | 0.87 | CNR2 (0.35) | CNR2CNR1 | |
| SCHEMBL26248104 | 0.83 | S1PR1 (0.41) | CNR1 | |
| SCHEMBL22527104 | 0.83 | HDAC1 (0.42) | CNR2CNR1 | |
| SCHEMBL26249486 | 0.81 | MPO (0.32) | — | |
| SCHEMBL22527234 | 0.80 | HDAC6 (0.46) | CNR2CNR1 | |
| SCHEMBL26253112 | 0.80 | MTNR1A (0.35) | CNR2CNR1 | |
| SCHEMBL26206480 | 0.79 | FFAR4 (0.39) | CNR2CNR1 | |
| SCHEMBL22526996 | 0.79 | CNR2 (0.36) | CNR2CNR1 | |
| SCHEMBL26253178 | 0.76 | MPO (0.35) | CNR2CNR1 | |
| SCHEMBL26248357 | 0.76 | MEN1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11746120-B2 | Stat degraders and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2023-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11746120-B2 | Stat degraders and uses thereof | STAT4, STAT1, STAT3 | CNR2 2461/4885CNR1 2602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.